PMDA announcement: Self-inspection notice for in vitro diagnostic products
自主点検通知（体外診断用医薬品）を掲載いたしました
Published: 2026-01-07 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
The Pharmaceuticals and Medical Devices Agency (PMDA) announced on 2026-01-07 that it had posted a self-inspection notice concerning in vitro diagnostic products. The title does not specify the inspection scope, intended recipients, or any deadline.
Business Impact
Companies handling in vitro diagnostic products may be affected by the self-inspection notice, although the title does not establish which companies or products are covered.
Recommended Action
Reviewing the official Japanese notice could clarify its intended recipients, inspection scope, and any deadlines.